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The long-term consequences of forebrain ischemia include delayed Parkinson’s syndrome. This study revealed delayed
neurodegeneration in the substantia nigra 8 weeks after 12.5 minutes of global ischemia in rat brain. Following neuronal loss of
30–40%incentralanddorsolateralstriatumatday3,neuronaldamageinthesubstantianigra(SN)wasassessedat4–8weeksusing
immunohistochemistry for glutamate decarboxylase 67 (GAD67), vesicular GABA transporter (VGAT), and calretinin (CR). At
day 56, the optical density of GAD67-, but not VGAT-, immunoreactivity in substantia nigra pars reticulata (SNR)—signiﬁcantly
decreased. CR-neurons concentrated in substantia nigra pars compacta (SNC) were reduced by 27% from day 3 (n = 5) to day 56
(n = 7, ANOVA, p<. 01). Movement coordination was impaired at day 56, as evaluated using beam-walking test (time-to-traverse
5.6±1.2secversus11.8±5.4sec; sham versus ischemia, p<. 05, n = 5, and 7, resp.). Our results demonstrate delayed impairment
of the GABAergic system components in SN and associated with movement deﬁcits after global ischemia.
1.Introduction
In the weeks to months following resuscitation after cardiac
arrest, delayed progressive secondary injury (postischemic
encephalopathy) gives rise to symptoms associated with
Parkinson’s syndrome (or called parkinsonism). Although
the symptoms resemble those of Parkinson’s disease (PD),
there is no profound loss of dopaminergic neurons in the
postischemic brains. The delayed brain injury is the major
concern in clinic, because it is much more severe than
the early (3–7 days) primary damage after global cerebral
ischemia [1–3]. About 30%–80% of survivors of resusci-
tation suﬀer progressive brain deterioration accompanied
by parenchymal lesions in the weeks following the initial
recovery from the acute ischemia [1, 4]. The encephalopa-
thy also happens after heart surgeries [5, 6]a n da c u t e
hypoxia [7, 8]. The patients may recover without symptoms
within 1-2 days after the insult but, in some cases, may
then undergo sudden deterioration, including coordination
disability, Parkinson’s syndrome, severe dementia, and/or
spastic paralysis associated with new brain lesions following
a symptom-free period averaging 2–4 weeks after forebrain
ischemia [2, 6] or hypoxia owing to acute carbon monoxide
intoxication [7, 8]. Recent studies revealed that the delayed
encephalopathy is a consequence of secondary ischemia [9].
In a rat model of global ischemia, a delayed loss of γ-
aminobutyric acid (GABA) containing interneurons in the
hippocampus coexisted with a decreased seizure threshold
[10]. The expression of Parkinsonism in humans and the
delayed vulnerability of the GABAergic interneurons in the
hippocampus stimulated our exploration of the long-term
impact of global ischemia on the GABA pathways within the
striatum-substantia nigra system.
GABA is the major inhibitory neurotransmitter in mam-
malianbrain;disturbanceoftheGABAergicsystemshasbeen
linked to both Parkinsonism [11] and epilepsy [12]. The
anatomy and function of substantia nigra (SN) has been the
focus of decades of research and thousands of publications.
Brieﬂy,thesubstantianigra(SN)inmidbrainisacomponent
of the basal ganglia GABAergic system receiving strong input
from the ipsilateral striatum and globus pallidus and plays
a pivotal role in the control of movement coordination
through inhibition [13]. Neurons within the substantia
nigra pars reticulata (SNR) are predominately GABAergic,2 Cardiovascular Psychiatry and Neurology
providing both local inhibitory synapses in the SNR and
the adjacent substantia nigra pars compacta (SNC), and
powerful inhibition to the thalamus and superior colliculus.
In addition to internal segment of the globus pallidus,
the SNR is a major output nucleus of the basal ganglia.
Inhibitory input to the SNR is derived from the medium
spiny neurons of the striatum. Dopaminergic (DAergic)
neurons in the SNC release dopamine to synaptic targets
including the striatum [13].
Animal studies have demonstrated that forebrain
ischemia causes postischemic encephalopathy [14]a n d
damage to the GABAergic system [15, 16]. The striatum is
vulnerable to transient forebrain ischemia. The dorsolateral
striatum has profound neuronal necrosis associated with a
marked decrease in GABA synthesis after global ischemia
[14, 17]. Extracellular levels of glutamate and GABA
increase rapidly following the onset of ischemia and return
to baseline quickly [15, 16]. But, multi-ischemic insults
instead of a single ischemic event induced a signiﬁcantly
higher extracellular glutamate level and reduced synthesis
of GABA, resulting in a signiﬁcantly higher excitotoxic
index (i.e., (glutamate × glycine)/GABA) in the injured
regions at 3 hours after reperfusion [15]. The result suggests
that decreased synthesis of GABA might contribute to the
enhanced ischemic injury in the striatum.
The synthesis of GABA in vertebrates including humans
is regulated through the activity of L-glutamate decar-
boxylases 65 and 67 (GAD65 and GAD67) [18]. GAD
is in close association with small vesicles in the axons
terminals of neurons. GAD catalyzes the synthesis of GABA
from glutamate [18]. GABAergic synaptic interactions with
DAergic neurons are present in the substantia nigra pars
compacta(SNC)andparsreticulata(SNR).GAD-containing
terminals make synaptic contacts with DAergic neurons in
SNC and SNR [13]. However, delayed postischemia changes
of the GABAergic system within the SN after the moderate
single forebrain ischemia have not yet been reported. The
presence of Parkinsonism following acute forebrain ischemia
prompted us to investigate the long-term changes in the
GABAergic system after an ischemic episode.
We hypothesized that at least part of the cerebral
impairment obtained in our previous studies [14, 19]c o u l d
be related to the damage of the GABAergic system in
brain regions critical for motor function, including striatum,
primary motor cortex, and substantia nigra. In order to
explore this hypothesis, in this study we examined acute and
chronic damage to the GABAergic system and coordination
of movement after global brain ischemia in adult rats. We
analyzed the diﬀerences induced by global ischemia with
immunohistochemical (IHC) methods with several markers
to expand our view of GABAergic system changes after brain
ischemia.
2.MaterialsandMethods
2.1. Transient Global Forebrain Ischemia. Adult male Wistar
rats, weighing 256–405g and aging 2.8 ± 0.6 months, were
subjected to 12.5 minutes (min) of global forebrain ischemia
produced by bilateral common carotid artery occlusion
plus systemic hypotension (40–50mmHg) following an
overnight fast. The University of Miami’s Animal Care and
Use Committee approved all procedures. Anesthesia was
induced with 3% halothane with the balance at 70% nitrous
oxide/30% oxygen. Animals were intubated endotracheally
and ventilated mechanically on a mixture of 0.5% halothane,
70% nitrous oxide, and a balance of oxygen. The femoral
arteries were catheterized to permit blood pressure moni-
toring and arterial sampling for blood-gas measurements.
Arterial PCO2 and PO2 were maintained in the normal
range by ventilatory adjustments. Rats were immobilized by
pancuronium bromide, 0.75mg/kg i.v. Rectal temperature
was continually measured and maintained at 37–37.5◦Ca n d
cranial temperature was separately monitored by a 29-gauge
thermocouple implanted into the left temporalis muscle
and maintained at 36–36.5◦C by warming lamps above the
rat’s body through the experiment. Blood was withdrawn
into a heparinized syringe to reduce the systemic blood
pressure to 40–50mmHg. Carotid ligatures were tightened
for 12.5 minutes, then the ligatures were removed, and the
warmed shed blood was reinfused to restore blood pressure
to normal. Physiological monitoring was continued for 3
hoursintothepostischemicperiod.Aftertheexperimentwas
ﬁnished, all wounds were inﬁltrated with 1% lidocaine. Rats
were placed in cages at room temperature with free access to
water and food. Sham rats (n = 5) received similar surgery
but not ischemia [14].
2.2. Histopathological and Immunohistochemical Studies.
Ratswerereanesthetized withhalothane and perfusedvia the
ascendingaortawitha2-minuteperfusionwithphysiological
saline then FAM (40% formaldehyde, glacial acetic acid, and
methanol, 1:1:8 by volume; ﬁnal formaldehyde concentra-
tion of 4%) for 18 minutes at a pressure of 100–120mmHg
on day 3 (n = 5), day 7 (n = 7), day 28 (n = 6), and day 56
(n = 7) after ischemia. The heads were immersed in FAM for
an overnight at 4◦C. The brains were removed and placed
in fresh FAM for an additional day. Coronal brain blocks
were embedded in paraﬃn, and sections (10μm thick) were
prepared at 250μm intervals. Sections from 3 levels (∼0.2,
3.3, and 5.3mm posterior to bregma) were employed for
histological examination [14, 15].
Adjacent sections were stained by hematoxylin and eosin
(H&E) or reacted for immunohistochemical visualization
of the GABA system. GAD67 is considered as the spe-
ciﬁc marker for GABAergic neurons and their processes
[20]. Mouse anti-GAD67 (MAB5406, Millipore/Chemicon,
Temecula,CA)ataworkingdilutionof1:750[21],antivesic-
ular GABA transporter (VGAT) produced in rabbit (V5764,
SIGMA) at 1:1500 [22], and rabbit anticalretinin (anti-CR)
[SP 13] (ab16694 Abcam) at 1:200 were used to detect
GABAergic neurons in brain [23]. Antineuronal nuclear
antibody (NeuN, MAB377, Chemicon, Temecula, CA) is
a speciﬁc antibody against neuronal nuclear protein and
stains normal neurons in brain at a working dilution of
1:200[24].Glialﬁbrillaryacidicprotein(GFAP,DakoCorp.,
Carpenteria, CA) was employed to detect active astrocytes at
dilution 1: 1500 [14].Cardiovascular Psychiatry and Neurology 3
Sections were incubated in 1.2% H2O2 for 20 minutes to
block endogenous peroxidase activity, were boiled in 10mM
citrate buﬀer, pH = 6.0 in a microwave for 15 minutes to
retrieve antigen, except those for GFAP labeling [21–24],
and, then, were incubated in primary antibodies at room
temperature: GAD, CR, and NeuN for 18 hours; VGAT for
1.5 hours; GFAP for 30 minutes. Sections were incubated
in the appropriate biotinylated secondary antibodies for
30 minutes. The Vectastain ABC method (Vector Labs,
Burlingame, CA) and 3, 3 -diaminobenzidine (DAB) were
used for visualization of primary antibody binding. Speciﬁc
staining was identiﬁed by the dark-brown appearance.
Two sections were on each slide. The second section was
counterstained by hematoxylin to facilitate identiﬁcation of
brain regions.
2.3. Immunocytochemistry Controls. For standard immuno-
peroxidase procedures, two important control slides are
included: one for negative control and one for positive
control.
Sections may nonspeciﬁcally absorb immunologic
reagents to cause false-positive results. For all primary
antibodies used, negative controls are accomplished by
replacing the primary antibody with sera not containing
the primary antibody. To detect the false-positive results,
negative controls were conducted with mouse IgG1 (X0931,
Dako, Carpenteria, CA) or Rabbit Immunoglobulin Fraction
(normal) (X0903, Dako, Carpenteria, CA) to replace the
speciﬁc primary antibodies. Its negativity validates the
positive immunolabeling under the study. Neurons were
counted if they exhibited a dark-brown reaction product
and had a visible nucleus.
Positive control is for conﬁrming negative reaction to be
considered truly negative, not resulting from the reduced
sensitivity of the reaction due to improper technique.
Positive control is a known histologic slide containing the
speciﬁc antigen. Preliminary experiments performed with
the speciﬁc antibodies and NeuN, not related to GABA,
were applied to normal (sham) rats. One slide containing
NeuN was added. Both GAD or VGAT and NeuN labeling
were extensive and intensive, which demonstrated that
the right method and skill were employed. Therefore, the
subsequent immunohistochemistry studies used only the
speciﬁc antibody. Slides from sham rats were processed in
parallel with sections from postischemic rats as the positive
control for the GAD67 and VGAT immunostaining. While
sham (positive-control) slide exhibited positive staining,
the decreased GAD67 or VGAT immunoreaction implies
decreased GABAergic markers in brains from postischemic
rats.
2.4. Neuronal Counting. We counted the total number of
neurons (normal, apoptotic, NeuN positive, or CR positive,
as deﬁned below for each study) in each brain region on
each hemisphere of a single 10um coronal brain section; the
average of both hemispheres counted as a single data point.
Neuronscontainingaroundorovoidclearnucleuswerecon-
sidered normal (or vital). The degree of ischemic injury was
quantiﬁed by counting numbers of normal neurons within
representative high-power microscopic ﬁelds in sections
stained with hematoxylin and eosin (H&E). For the striatum
(0.2mm posterior to bregma) and hippocampus (3.3mm
posterior to bregma), we also counted apoptotic neurons
as identiﬁed by their shrunken and eosinophilic appearance
in H&E-stained sections. For the neocortex, we counted all
the apoptotic neurons in the full extent of neocortex in
three sections 0.2mm, 3.3, and 5.3mm posterior to bregma.
Apoptotic neurons in the thalamus and hypothalamus were
counted in a single section 3.3mm posterior to bregma.
Within the substantia nigra in a single section at 5.3mm
posterior to bregma, we counted apoptotic neurons in H&E-
stainedsections,andNeuN-orCR-immunopositive neurons
[14, 15, 25].
SincethestrongimmunoreactivityforGAD67andVGAT
is present in the neuronal processes, not somata, it is
diﬃcult to count the number of GAD-positive neurons in
substantia nigra. Optical density was measured by digitizing
the slides using a slide scanner (Pathscan Enabler IV Meyer
Instruments) and identical scan settings for all slides. After
conversion to 8-bit grayscale images without rescaling, the
optical density was calibrated using built-in functions of the
image analysis software ImageJ (NIH). To quantify optical
density, regions of interest consisting of 0.063mm2 circles
were positioned within the SNR. In addition, the loss of
GAD67- and VGAT- immunoreactivity in SN was presented
by showing the raw images [26].
3. Behavioral Testing
3.1. Beam-Walking Test. A beam-walking test was applied to
assess coordination and integration of motor movements in
order to evaluate neurological functional recovery in the rats
after forebrain ischemia.
The employed beam-walking apparatus is the typical
design for rat to test motor coordination after brain trauma
and ischemia [27, 28], which consisted of a plastic beam
(1.75cm wide and 100cm long, positioned at a height
of 65 cm by 2 supporting legs) connected to a platform
(12.5 × 12.5cm) in each end. A black box (W25 × D25
× H20.5cm) open toward the beam is installed on one
platform. Performance was rated on a 0–6 point scale: 0
points if the rat was unable to stay on the beam; 1 point,
able only to stay on the beam; 2 points, tried to traverse the
beam but fell; 3 points, traversed the beam with more than
50% hind-limb foot-slips; 4 points, traversed the beam with
fewer than 50% foot slips; 5 points, only one slip; 6 points,
traversed the beam with no slips [27, 28]. We modiﬁed the
test: when the rat was able to traverse without slipping, that
is, reached point 6, the traversal time was recorded by a
stopwatch. The time recording began when rat extended a
forepawfromtheplatformontothebeamtostartthetraverse
and stopped when a forepaw was crossing the beam forward
into the black box.
3.2. Postural Reﬂex Test. Because macro infarction may
appear in striatum and cortex around 1 month or later after4 Cardiovascular Psychiatry and Neurology
Table 1: Physiological variables in rats with 3–56 days of survival. Values represent mean ± SD (MAP, mean arterial blood pressure).
Group n Weight (g) Age (month) MAP (mm Hg) pH (units) pCO2 (mmHg) pO2 (mm Hg) Glucose (mg/dl)
3 day 5 365 ±10 3.4 ±0.4 127 ±12 7.390 ±.04 41.1 ±3.1 123.8 ±23.7 160 ±17
7 day 7 322 ±49 3.0 ±0.4 125 ±11 7.374 ±.04 41.2 ±3.5 148.2 ±29.0 145 ±15
4 week 6 288 ±29 2.7 ±0.2 133 ±12 7.374 ±.04 39.5 ±4.1 145.0 ±17.8 144 ±24
8 week 7 319 ±46 2.7 ±0.5 129 ±10 7.428 ±.08 38.2 ±2.7 126.1 ±17.2 139 ±23
Sham 4 304 ±23 2.7 ±0.4 137 ±11 7.395 ±.05 39.8 ±4.2 157.0 ±16.4 142 ±14
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Figure1:Thenumberofnormal(i.e.,vital)neuronsinthestriatum
decreases rapidly after global ischemia. Bar graph shows normal
neurons (mean ± SD) signiﬁcantly decreased in rat striatum at
days 3–56 after 12.5 minutes of transient forebrain ischemia, per
high-power (40 ×) microscopic ﬁeld (∗indicates the signiﬁcant
diﬀerence, ischemic versus sham groups, p ≤ .03, ANOVA, post
hoc Tukey HSD).
the forebrain ischemia [14], a standardized neurobehavioral
battery, the postural reﬂex test, applied routinely to test
paralysis in rats subjected brain infarction in middle cerebral
artery territory was employed in this study on the impact
of global ischemia [28]. The rats are held by the tail 50cm
above a table. Intact rats extend both forelimbs toward the
table. The rats displaying this behavior are assigned a score
of 0. If the rat ﬂexes one forelimb, score 1, then, the rat is
given the lateral push test: placing the rat on the table and
applying lateral pressure behind the shoulders in the left and
right directions. If the rat is unable to resist the force equally
in both directions, it receives score 2 [28].
The tests were conducted on days 1, 2, 7, 14, 28, and 56
following ischemia.
4.StatisticalAnalysis
Results were presented as mean ± SD. Data were analyzed by
a t-test or one-way analysis of variance (ANOVA) followed
by Dunnett’s test for multiple comparisons, unless otherwise
noted. Signiﬁcance was accepted for p<. 05.
5. Results
5.1. Physiological Variables. Preischemic physiological vari-
ables were in normal ranges in all groups, and no signiﬁcant
intergroup diﬀerences existed (Table 1).
5.2. Neuronal Histopathology. All rats showed mild necrosis
in the dorsolateral striatum, and several rats had mild
damage in the central striatum at days 3–7. No additional
necrotic injury within the striatum was observed at days
28 and 56. Normal neurons signiﬁcantly decreased in both
dorsolateral and central striatum at days 3–56. The numbers
were 60 ± 8a td a y3( n = 5), 54 ± 12 at day 7 (n = 7),
70 ± 15 at day 28 (n = 6), 68 ± 4a td a y5 6( n = 7) in
dorsolateral striatum and 67±15, 59±16, 69±8, and 66±10
in central striatum while the numbers of normal neurons in
sham rats (n = 4) were 104±13 in dorsolateral striatum and
94±5 in central striatum. The ischemia reduced the number
of normal neurons in striatum (see Figure 1,m e a n± S.D.,
ANOVA, p ≤ .01). Moderate-to-severe “spongy” changes
(deﬁned as empty spaces in histological sections) in striatum
were present at day 56 in 5 of 7 rats (Figure 2(d)).
The number of normal neurons in hippocampal CA1
sectorwassigniﬁcantlyreducedfromday3today56.Normal
neurons in CA1 are 24 ± 18 (day 3, n = 5), 15 ± 8( d a y
7, n = 7), 24 ± 20 (4 week, n = 6) and 21 ± 5( 8w e e k ,
n = 7); 438 ± 73 (sham, n = 4) (p<. 001, 4 ischemic groups
versusshamgroup).Micro-infarctionwasseeninCA1sector
at weeks 4-8.
The cerebral neocortex showed only very mild damage
(few or no necrotic neurons) at days 3 and 7, and no necrosis
at days 28 and 56.
No necrotic neurons or infarction was observed in
midbrain including the SN at days 3–56. Consistent with
this,thetotalnumberofNeuN-positiveneuronsinthedorsal
portion of the SN, including SNC and SNL, was 212 ± 42
versus 270±42 (ischemic rats, n = 6 versus sham rats, n = 3;
p>. 05) at day 56.
Many eosinophilic and shrunken neurons (indicating
apoptosis) were seen in midbrain including substantia nigra
(SN) at day 56 (Figures 2(a)–2(c)). Six of 7 ischemic rats
displayed apoptotic neurons in SN. Some apoptotic neurons
were noticed in the perivascular regions (Figure 2(c)). The
numbers of apoptotic neurons in the SN at day 56 are
20 ± 13 (ischemia, n = 7) versus 4 ± 3 (sham, n =
4, p<. 05, ANOVA). In the midbrain beyond the SN,
81 ± 70 versus 16 ± 10 were detected (p = .05, t-test,
sham versus ischemia at day 56). These data are consistent
with delayed neurodegeneration. Eosinophilic and shrunken
neurons were also detected in hypothalamus, thalamus, and
cortex at day 56. The numbers (ischemic versus sham) were
54 ± 36 versus 13 ± 11 in hypothalamus (p<. 05, t-test);
113 ± 89 versus 36 ± 10 in thalamus and subthalamus;
and 213 ± 140 versus 90 ± 44 in cortex (sum of the cells
counted in the 3 standard levels) (p>. 05, t-test, sham versusCardiovascular Psychiatry and Neurology 5
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Figure 2: Neurodegeneration in substantia nigra (SN) and striatum at day 56 following 12.5 minutes of transient global ischemia in rats
(H&E staining). Eosinophilic and shrunken neurons (arrows) are present in SN ((a)–(c)). (b) is a magniﬁed view of the boxed area in (a).
Eosinophilicandshrunkenneuronsareadjacenttoinjuredbloodvessels(c).Striatashowsevereormoderatespongychanges((d),(e))which
are proximate to abnormal perivascular area (e). The active astrocytes were detected by anti-GFAP in SN of sham rat (f) and in ischemia rat
at day 56 (g). No astrogliosis was observed in both groups.
ischemia at day 56). GFAP-immunoreactivity conﬁrmed that
no signiﬁcant astrogliosis occurred within the SN at days
3–56 (Figures 2(f) and 2(g)). However, the neurons with
shrunken cell bodies and condensed-chromatin nuclei were
clearly labeled by the antibody against NeuN.
5.3. Immunohistochemical Analysis of GABAergic System in
Substantia Nigra. In sham animals, immunoreactivity (ir)
for GAD67 and VGAT was dense in the SNR, and CR-ir
was highly concentrated in midbrain, especially in the SNC
(Figure 3).
5.4. Glutamate Decarboxylase 67 (GAD67) Immunocytochem-
istry. Intense GAD67 immunoreactivity (GAD67-ir) was
present in the substantia nigra (SN) (Figure 4). The dense
and long GAD67 ﬁbers formed a network, which was
especially concentrated in SNR and to a lesser extent in SNL
and SNC in all of the sham (Figures 4(a) and 4(b))a n d
ischemic rats (Figures 4(c)–4(h)). At higher magniﬁcation,
labeled proﬁles typically contained numerous small clear
vesicles. Dense punctate patches of immunoreactivity were
observed throughout SN. GAD67-ir was visualized mainly in
neuronal processes: axon and dendrites and the puncta were
closely apposed to the processes. The processes of GAD67-ir
neurons were long and formed a ﬁbrous network within the
SNR (Figure 4(b)).
Numerous GAD67-ir terminals formed a dense pericel-
lular plexus around immunonegative cell bodies of neu-
rons (Figure 4(a)). Few positively labeled cell bodies were
observed. Numerous GAD67 puncta surrounded unstained
neurons (Figure 4(b)). The nuclei of neurons remained
unstained. Ischemic rats at day 56 displayed decreased
GAD67-ir including lesser number of puncta and lower6 Cardiovascular Psychiatry and Neurology
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Figure 3: Illustration of GAD67, VGAT, and CR immunostaining in substantia nigra (SN) and the surrounding regions in sham rat on
coronal midbrain sections. Immunoreactivity (ir) of GAD and VGAT is high in substantia nigra par reticulata (SNR). The strong CR-ir
displays in pars compacta (SNC) and lateralis (SNL) while weak CR-ir present in SNR.
density (Figures 4(c)–4(h)). These qualitative observations
supported results using quantiﬁcation of optical density
of the immunostaining (Figure 5). We found a statistically
signiﬁcant decrease relative to sham at day 56 although all
the postischemic time points were below the sham values.
5.5. VGAT Immunohistochemical Analysis. VGAT is reported
to selectively identify GABAergic nerve terminals [29].
Immunohistochemical analysis showed numerous VGAT
immunopositive puncta in SN from sham animals (Figures
3, 6(a),a n d6(b)). Intensive punctuate immunostaining was
present in the processes of neurons including axon and
dendrites, and the long processes formed a ﬁber network.
Intense VGAT-immunoreactivity (VGAT-ir) was observed
in the SNR, SNL, and SNC (Figure 6). VGAT-ir was more
intense and uniform in SN in sham rats (Figure 6(a)). At
higher magniﬁcation, VGAT-ir was primarily detected in
small processes but was absent in cell bodies; the puncta
encircled neuronal soma (Figure 6(b)). Ischemia appeared
to decrease VGAT expression in SN. Ischemic rats showed
less puncta and an apparent lower density of VGAT-
ir (Figures 6(c)–6(h)). Although VGAT-immunoreactivity
appeared signiﬁcantly less intense in postischemic rats, no
signiﬁcant quantitative diﬀerences in gross optical density
were observed owing to the high degree of variability in the
intensity of immunoreactivity even within the sham group
(data not shown).
5.6. Calretinin (CR) Immunoreactivity. Calretinin (CR) has
been used to detect a subpopulation of GABAergic interneu-
rons [30]. In our study, calretinin-like immunoreactivity was
detected in the midbrain at all time points after ischemia.
Within the SN, calretinin was exclusively observed in cell
bodies and short dendritic processes (Figure 7). In normal
rats, CR-immunopositive neurons were densely distributed
in SNC, especially in the ventral tier, and many CR-neurons
were seen in SN pars lateralis (SNL), which formed a
diagonal band-like zone (Figure 7(a)). Several CR-neurons
were observed in SNR. During days 3–56 following ischemia,
the numbers of CR-neurons progressively declined. The
numbers of CR-positive neurons in the entire SNC were 156
± 23 in sham group (n = 3); 144 ± 15 at day 3 (n = 5);
128 ± 24 at day 7 (n = 6); 95 ± 12 at day 28 (n = 6), and
100 ± 16 at day 56 (n = 7). Decrease of CR-ir neurons was
detected from day 28 through day 56: a 27% decrease from
day 3 to day 56 (ANOVA, p<. 01), a 26% decrease from day
7t od a y2 8(p = .01), and a 18% decrease from day 7 to day
56 (p<. 05) was observed. No signiﬁcant diﬀerences were
detected between the day 3 and day 7 or between days 3–7
and sham (p>. 05) (see Figure 8). These data demonstrate a
delayed loss of CR-ir beginning after day 7.
5.7. Behavioral Analysis. All of the 30 rats participated in the
study received the following behavioral tests.
5.7.1. Beam-Walking Test (BWT). Rats were trained to walk
on the beam to assess the rats ability to maintain balance
before surgery. First, rats were put on the platform. All of
rats moved around slowly on the platform for 10–15 minutes
and, then, began to try to traverse. They walked on the beam
faster and faster during the training. Finally, rats ran easily
alongthebeamwithoutfaults.Theyappearedtowelltolerate
the beam-walking test because they voluntarily repeated the
traversing, making round-trips between the black box and
the platform during the training. The last tests were done on
day 56 following ischemia (n = 7). Sham rats (n = 5) were
also tested.
Aftertraining, the preischemia traversing beam scorewas
6 for all 30 rats. The traversing score of sham rats reached
6 point (no faults) at 48 hours after surgery while ischemicCardiovascular Psychiatry and Neurology 7
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Figure 4: Coronal sections of the ventral mesencephalon showing GAD67-immunoreactivity (GAD-ir) in substantia nigra (SN) at day 56
after 12.5 minutes of global ischemia. The dense GAD-ir is in SN. (a) GAD-ir ﬁber network is especially prominent in substantia nigra par
reticulata (SNR), pars compata (SNC), and pars lateralis (SNL) in sham rats. (b) higher magniﬁcation of boxed area in (a). The processes
and the cell body are encircled by GAD67+ puncta. GAD-ir puncta are closely apposed to GAD-ir dendrites and outline a cell body. Note
the GAD67+ puncta in contact with the soma and proximal dendrites leaving the cell body. (c)–(f) distribution of GAD-ir from 4 diﬀerent
ischemia rats. (g)-(h) Higher magniﬁcation of boxed areas in (c) and (f), respectively. As compare, to sham rats, ischemic rats showed
an evident reduction of GAD-ir in SN: the number and density of GAD-puncta are decreased. (b), (g), and (h) are counterstained by
hematoxylin.8 Cardiovascular Psychiatry and Neurology
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Figure 5: Quantitative analysis of GAD67-immunohistochemistry
optical density (mean ± SEM). ∗indicates the diﬀerence from sham
rats, p<. 04, ANOVA, Games-Howell post hoc test).
rats did not reach 6 until day 56. Compared to sham rats,
the ischemia rats had signiﬁcantly lower scores at days 1,
2, and 7 after the insult (see Figure 9(a)). At day 56, the
score of ischemia group reached 6; however, the ischemic
rats traversed slower than sham rats, and the mean time
for traverse was 11.8 ± 5.4 (ischemia, n = 7) versus 5.6
± 1.2 seconds (sham, n = 5) (Figure 9(b)). Compared
to preischemia the rats walked signiﬁcantly slower at day
56: the traverse time was 4.88 ± 0.92 versus 11.8 ± 5.4
seconds (postischemic group, baseline (day 0 versus day 56;
Figure 9(b)). However, sham rats did not traverse slower in
day 56 than presurgery (5.16 ± 0.66 versus 5.6 ± 1.2 seconds;
sham group, baseline versus day 56). This indicates ischemia
rats took more time to ﬁnish traverse due to brain injury, not
aging or surgery.
5.7.2. Postural Reﬂex Test. The test was conducted on days
1, 2, 7, 14, 28, and 56 before BWT. All of rats scored 0
(no deﬁcit) during the whole 8 weeks after ischemia. This
is consistent with our histological analysis and demonstrates
the lack of macroinfarction.
6. Discussion
This study oﬀers evidence that the GABAergic system in
substantia nigra (SN) underwent delayed degeneration at 4–
8 weeks following a single episode of 12.5-min forebrain
ischemia, including a decrease of GAD67-, VGAT- and CR-
immunoreactivity; no direct ischemic injury was detected in
theSNduringtheacutepostischemicstage(postinjurydays3
and 7). The behavioral recovery was assessed with the beam-
walking test to detect motor coordination revealing a delayed
and attenuated recovery. Thus, the present study extended
our understanding of delayed postischemic encephalopathy.
We demonstrated that the substantia nigra contains
a high density of immunoreactivity for markers of the
GABAergic system in normal rats. This is similar to previous
observations [13, 26]. A previous study reported that
neurons in SN are resistant to a single moderate episode of
ischemia. SN damage was not observed at the ﬁrst 7 days
[31]. A severe (20-minute) forebrain ischemia may induce
delayed regression in SNR at 3 weeks, which depended
on the extent of initial striatal damage [32]. This shows
that moderate ischemia induced SN degeneration at the 4th
weekwhilemild-to-moderateinjurywasdetectedinstriatum
at days 3–7 after the insult. Evidence for substantia nigra
regression included reduction in the density of GAD67 and
VGAT ﬁber networks in SNR and a decline in numbers
of CR-neurons in SNC. This degeneration might be the
regression secondary to the preceding striatal injury and
mightbeinducedbyinjuredbloodvesselssincedegeneration
appeared in some cases adjacent to abnormal perivascular
regions [19], and endothelial degeneration persists in brain
for at least 10 weeks [14].
6.1. Ischemia Reduces GAD67 Expression in SN. GAD67-ir
proﬁles observed in sham animals in the present study are
similar to previous studies [13, 33–36]. GAD67 immunocy-
tochemistry is used to be studied by labeling the GABAergic
neurons and synapses [26, 37] and has been extensively used
to identify GABAergic populations throughout the brain
[38].GreaterconcentrationofGAD67-irhasbeenpreviously
associated with the increased GABA synthesis [18]. Electron
microscopicandlightmicroscopicstudiesdemonstratedthat
GAD67 puncta are indeed in axon terminals, synaptic vesi-
cles, and dendrites but not in neuronal soma in substantia
nigra and other regions [13, 34–36].
GABAergic eﬀerent neurons in striatum are highly
vulnerable to ischemia; GAD67-immunoreactivity markedly
decreases associated with the death of striatal eﬀerent neu-
rons in the lesioned dorsal striatum and markedly decreases
the GABA synthesis in SRN induced by global ischemia [17].
In addition, striatal ischemia induced by middle cerebral
artery occlusion (MCAO) leads to a robust decrease of
GAD67 immunoreactivity in the ipsilateral SNR for at least
94 days [26].
Measurement of cellular GAD expression is crucial for
the present study. Because of the diﬃculty of acquiring
protein samples from small, speciﬁc brain regions for West-
ern blots, previous studies have relied on in situ hybridiza-
tion (ISH) for isoforms of GAD mRNA or GAD protein
immunohistochemistry (IHC) as markers for cell counts.
These studies found that the number of neurons expressing
GAD67 mRNA is signiﬁcantly less than the number of
neurons expressing GAD67 protein [21], suggesting that for
this protein immunohistochemistry may be more reliable
than mRNA detection. Thus, IHC was chosen in the present
study. Based on GAD67 immunoreactivity, GAD expression
in SN was decreased at the 8th week after 12.5 minutes of
transient forebrain ischemia.
6.2. Ischemia and VGAT Expression in SN. Vesicular GABA
transporter (VGAT) is an integral membrane protein and
a neurotransmitter transporter in GABAergic neurons [39].
Recent studies reported that focal brain ischemia decreases
VGAT in the injured brain regions during the 72 hours after
reperfusion [40]. VGAT mediates the transport of GABA
from cytosol into synaptic vesicles [40]. VGAT protein-
containing synaptic terminals, neuropil, and somata wereCardiovascular Psychiatry and Neurology 9
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Figure 6: VGAT immunolabeling in SN in coronal midbrain section of rats after 12.5 minutes of global ischemia at day 56. (a) VGAT-ir in
sham rat. (b) Higher magniﬁcation of boxed area in (a). The insertion with hematoxylin counterstaining presents a higher magniﬁcation
of VGAT-ir. Immunohistochemical analysis shows abundant puncta of VGAT-positive dots, and some of these puncta encircle an unlabeled
neuron’s body and its dendrites. (c)–(g): VGAT-ir in 5 ischemic rats at day 56 after injury. (h): higher magniﬁcation of boxed area in (g)
shows lower density and less amount of VGAT puncta and ﬁber network than sham rat.
visualized by IHC. The VGAT-ir in our study is similar
to the VGAT labeling observed in a previous study [41].
GAD 67 and VGAT couple in synaptic vesicles (SVs). GABA
synthesized by GAD67 is transported into SVs by VGAT
[41].InhibitingGADdecreasesVGATactivity[41].Thismay
explain why the two diﬀerent GABA cytological markers,
GAD67andVGAT,showedsimilartopographicdistributions
in this study. VGAT-ir in the entire SNR appeared clearly less
intense in ischemic rats in the present study, but the high
degree of variability in gross optical density in the regions
of interest (ROI) of sham group resulted in no signiﬁcant
diﬀerences on VGAT-ir. Neurotransmitters released into10 Cardiovascular Psychiatry and Neurology
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Figure 7: Distribution of calretinin (CR) neurons through substantia nigra (SN) in coronal sections of rats at level ∼− 5.3mm to bregma
at 56 days of survival. (a) In a sham rat, numerous CR-ir neurons were detected in pars compacta (SNC) and to a lesser extent in pars
lateralis (SNL); (b) is the magniﬁcation of the boxed region in (a); the insert shows a higher magniﬁcation of neurons. (c)–(h) Calretinin
immunoreactivity in six ischemic rats after a 12.5-minute period of global ischemia at day 56. The number of CR-neurons was reduced in
the SN after ischemia.
the synaptic cleft will be cleared by active reuptake into
the surrounding neurons, which is mediated by plasma
membrane transporters [42]; and the transport from cytosol
into synaptic vesicles is mediated by vesicular transporters
in synaptic vesicles [40]. Decrease of nigral GAD-expression
should result in the reduction of GABA synthesis and
release in SN, which may decrease the inhibition on DAergic
neurons to play a role in Parkinsonism development after
forebrain ischemia.
6.3. Ischemia Reduces Calretinin (CR) Immunoreactive
GABAergic Neurons in SN. The present study found thatCardiovascular Psychiatry and Neurology 11
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Figure 8:CR-irneurons are decreased 4–8 weeks after 12.5 minutes
of global ischemia (mean ± SD). The bar graph shows the numbers
of CR-neurons in the entire SN at level 5.3mm posterior to
bregma are markedly reduced at days 28 and 56 (∗indicates the
signiﬁcant diﬀerence compared to sham, day 3 and day 7; p<. 01,
ANOVA, post hoc Tukey HSD). No other signiﬁcant diﬀerences
were detected.
the CR-neurons in SN decreased at weeks 4 and 8 after
12.5 minutes of forebrain ischemia. However, the anti-NeuN
immunolabeling failed to detect the neuronal reduction
within the SN, owing to the numerous cell types within
this region and the relatively small number of CR-neurons.
Another possibility is that apoptotic and necrotic neurons
can be labeled by the NeuN antibody (neuron-speciﬁc
nuclearantigen).Inthepresentstudy,weobservedthatsome
neurons with apoptotic features (Figures 2(a)–2(c))w e r e
labeled by the NeuN antibody. This suggests that NeuN-
positive staining of injured neurons may occur if the nuclei
have not been phagocytosed or otherwise removed. We
believe that the apoptotic neurons were stained by NeuN
antibody but were not labeled by CR antibody, likely due to
a rapid loss of CR protein after injury. Thus, the loss of CR-ir
neurons may be reﬂected in the apoptotic neurons detected
by NeuN.
GABA neurons can be divided into diﬀerent subgroup
based on their expression of calcium-binding proteins:
calretinin (CR), calbindin (CB), and parvalbumin (PV)
[30]. Although calcium binding proteins are hypothesized
to maintain calcium-homeostasis, a recent study suggests
that calcium-binding proteins do not confer resistance to
ischemic injury [17]. Damage to striatonigral pathway leads
to the subsequent striatal decline of GABA release and
progressive GABAergic neuronal loss, which contributes to a
delayed and progressive loss of neurons in SNR by a decrease
in the inhibitory striatal input [43]. In SNC, about 50% of
CR-positive neurons are GABAergic neurons and 50% are
others [44, 45].
Dopaminergic (DAergic) neurons do not appear to
be selectively vulnerable to ischemia [26]. In rats, striatal
ischemia induced by 2-hour MCAO kills striatal neurons
and leads to a tremendous decrease of GABAergic pathway
in the ipsilateral SNR at days 3–94 following ischemia
while not reducing DAergic neurons in SNC [26]. Since the
striatal injury induced by 12.5-minute forebrain ischemia is
much milder than than by the 2-hours MCAo, logically the
forebrain ischemia in the present study should not decrease
the DAergic neurons in SN. Calretinin provides protection
against degeneration of DAergic neurons in SNC [25, 45]. In
Parkinson’s disease (PD) patients, the CR-positive DAergic
n e u r o n sa p p e a rt ob el e s sv u l n e r a b l et on e u r o d e g e n e r a t i o n
[25]. In the postischemic/hypoxic parkinsonism patients,
SNC is spared from the injury (see Section 6.7 below). Thus,
we assume the diminished CR-ir neurons in SNC in the
present study to be GABAergic.
6.4. GABA System Controls Activity of DAergic Neurons.
Parkinson’s disease (PD) is associated with the progressive
loss of dopaminergic neurons in substantia nigra pars
compacta (SNC) and their axons projecting to striatum by
unknown causes [46]. However, DAergic neurons are under
GABAergic system control. A strong GABAergic input via
striatonigral pathway innervates the DAergic neurons and is
central to normal function of this complex neuronal system
[13].
DAergic neurons are concentrated in SNC and involved
in the feedback loops within the basal ganglia [47]. The
GABAergic pathway exerts a direct regulatory eﬀect on
the activity of nigral DAergic projection [48]. The striatal
dopamine release is modulated by ipsilateral intranigral
GABA via direct action on the nigraostriatal projection [48].
Thus, decrease of GABA in the SN will inﬂuence the amount
of dopamine in the striatum in the present study.
GABAergicinputswithintheSNoriginatefromstriatum,
globus pallidus, and local nigral neurons [26]. The majority
of the striatonigral pathway is the aﬀerent projection into
the SNR from the GABAergic eﬀerent neurons in striatum.
The local nigral GABAergic neurons in the SNR and SNC
strongly inhibit DAergic neurons in the SNC [49]. Recurrent
inhibition is a hallmark of DAergic ﬁring patterns and
dopamine release in the striatum [49]. In addition, globus
pallidus (GP) exerts powerful control over the SNR input
and subsequent control over the DA neurons via SNR [49].
Decrease of GABAergic aﬀerent input to the SNR results
in the disinhibition of GABAergic neurons in SNR and a
subsequent decrease in the ﬁring DAergic neurons whereas
increase of burst ﬁring in DAergic neurons is associated with
a signiﬁcant increase of extracellular dopamine in striatum
[49]. Thus, the degeneration of GABA system in SN might
decrease the dopamine (DA) in striatum through the disin-
hibition of SNR GABAergic neurons to reduce the striatal
DA and subsequently induce the inhibition of movement. In
future studies, the amount of DA and GABA in striatum and
SN after ischemia should be assessed. Function studies using
electrophysiological approaches will be required to fully
elucidate the impact of delayed GABAergic degeneration
after global ischemia.
The DAergic neurons in the SNC and SNR receive dense
synaptic input from GABAergic terminals [47]. More than
70% of the terminals aﬀerent to the DAergic neurons in
SNC are GABAergic the major synaptic input is derived from
striatum via striatonigral pathway; striatonigral terminals
form the synapses at the dendrites and perikarya of DA12 Cardiovascular Psychiatry and Neurology
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Figure 9:Functionalrecoveryafterglobalischemiawastestedusingthebeam-walkingtest(BWT).(a)Themeanneurologicalscores(ascore
of 6 equals normal behavior) by beam-walking test before and after ischemia at days 1, 2, 7, 14, 28, and 56. The ability of the rats to walk on
the beam is decreased during the acute phase after global ischemia but gradually recovers (mean ± SEM; ∗p<. 01, paired two-tailed T-Tests
assuming unequal variances). (b) The time for beam traverse before and at day 56 after ischemia. Despite the improvement in the qualitative
scoring (i.e., no foot faults), the ischemic rats were much slower than sham or baseline. Because the ischemic rats were not able to complete
the traverse until day 56, these are the only time points available. ∗indicates signiﬁcant diﬀerence between preischemia and postischemia in
(a) and the diﬀerence between sham and ischemia group at day 56 in (b) (mean ± SEM; p<. 02; ischemia day 56 versus either sham or
baseline, ANOVA, Tukey HSD post hoc test between all four groups).
neurons in the whole substantia nigra [47]. Approximately
80% of the GABAergic synapses are on the perikarya and
large dendrites [13]. Therefore, DAergic neurons are under
a powerful inhibitory control from the GABAergic system.
After global ischemia, a decrease of the striatonigral eﬀerent
to SN may inﬂuence the function of DAergic neurons, which
in turn might lead to the disturbance of dopamine release in
striatum and interfere with motor coordination [49].
6.5. Functional Considerations
Degeneration of GABA System May Inﬂuence the Function of
DAergic Neurons. The basal ganglia, of which the striatum
(caudate nucleus and putamen) and SN form a functional
unit, are a motor coordination circuit. Degeneration of the
DAergic projection from the SNC to the striatum is directly
involved in the development of classic parkinsonian motor
symptoms. The substantia nigra reticulate (SNR) is one
of two major output nuclei of the basal ganglia. Normal
motor activity is dependent on coordinated striatonigral
and striatopallidal output, which regulated substantia nigra
output, which in turn regulates dopaminergic substantia
nigraoutput[50].TheoutputneuronsofstriatumuseGABA
as their principal transmitter colocalized with the neu-
ropeptides enkephalin (Enk) or substance P (SP)/dynorphin
(Dyn). Striatal neurons projecting directly to the output
structures use GABA, SP,a n dDyn while neurons pro-
jecting to the globus pallidus (GP) use GABA and Enk
[51]. Striatal neurons that express dynorphin (Dyn)a n d
substance P (SP) provide an inhibitory input to SNR.
Striatal neurons containing enkephalin (Enk)p r o v i d ea n
inhibitory input to the GP. Pallidal neurons provide an
inhibitory input to subthalamus. The subthalamic provides
excitatory input to SNR. GABAergic projection neurons in
SNR inhibit the neurons in thalamus which in turn project
to posterior regions of the frontal lobe (motor-related),
superior colliculus, and pedunculopontine nucleus (PPN)
t ol e a dan o r m a lb e h a v i o r a la c t i v i t y[ 51, 52]. These nuclei
form the basal ganglia-thalamo-cortical network, motor
circuit. Neurons expressing Enk and SP are located in dorsal
striatum. All of the Enk-, Dyn-,a n dSP-expressing neurons
u s eG A B Aa sat r a n s m i t t e r[ 50]. Dopamine exerts diﬀerent
eﬀects on pallidal-projecting/Enk-expressing neurons, and
nigral-projecting/SP- and Dyn-expressing striatal neurons
[50]. The neurons in dorsal striatum are more vulnera-
ble to ischemia than others. GABAergic eﬀerent neurons
expressing Enk and SP are greatly decreased by ischemia
[17]. Global brain ischemia signiﬁcantly injures neurons
in dorsal striatum while GP appears unaﬀected [14, 19].
The clinical appearance of movement disorders correlates
with the striatal dopamine reduction owing to the DAergic
neuronal loss in Parkinson’s disease [50, 51]. But, striatal
ischemia does not reduce DAergic neurons. Ischemia reduces
the dopamine’s targets and decreases the GABAergic inputs
in SN [26]. Whether the ischemic injury can initiate aCardiovascular Psychiatry and Neurology 13
disturbance of striatal dopamine release to induce the motor
inhibition needs to be investigated in the future studies.
However,thereductionofGABAinSNRmayproducemotor
inhibition, dyskinesias [51, 52]. Therefore, the retrograde
degeneration of GABA system in SN might reduce GABA in
SNR. Combined with a 30%–40% of normal-neurons loss
in dorsal striatum produced by ischemia, impaired motor
control may be a direct consequence of the degeneration
of GABA systems in the SN. Behavioral impairment could
be related to the damage of the other brain regions critical
for motor (primary motor cortex). However, there was
no paralysis in the experimental rats; thus, the pyramidal
system function seemed intact. The animals slowness on
beam traverse implies that postischemic animals might
be hampered by the disturbance of coordination, that is,
bradykinesia, due to signiﬁcant GABA system degeneration
in the SN and neuronal loss in striatum after transient global
ischemia. It should be noted that Huntington’s disease (HD)
is associated with excitotoxic neurodegeneration of medium
spiny neurons (MSNs) in the striatum. These neurons are
also acutely vulnerable to ischemia. Loss of these MSNs
in HD is associated with chorea. Our results also show
striatal degeneration in addition to the diminished GAD67
immunoreactivity in the SNR while previous studies suggest
no loss of dopamine neurons in the SNC. In this context, we
propose that the combination of GABAergic degeneration
in the SNR and other targets of global ischemia gives rise
to a net loss of dopamine release in the striatum and may
represent an alternative path to Parkinson-like symptoms in
the absence of overt loss of dopamine neurons.
6.6.StriatalIschemiaProducesNigralRetrogradeDegeneration
in Humans. In humans, striatal infarction, not cortical
infarction, leads to the retrograde degeneration in the ipsi-
lateral substantia nigra, an area remote from the infarct and
unlikely to be directly inﬂuence by ischemia. This similarly
occurs in rat after occlusion of middle cerebral artery. The
degeneration appears at day 14 after stroke on average in
patients [53, 54]. Since GAD67 [55] and calretinin [23]a r e
found in human brain, the present study can be considered
comparable to the pathological process in humans.
6.7. Postischemic/hypoxic Parkinson’s Syndrome in Patients.
Parkinsonism, a movement disorder, has been observed in
the patients awoke from the global brain ischemia or hypoxia
induced by cardiac arrest (CA) resuscitation [56–60], heart
surgery [6], and hypoxia, including carbon monoxide
(CO) poisoning [61–66]. The symptoms, including rigidity,
maskedface,short-stepgait,andakinesia/bradykinesia,show
up at 7–40 days after the insults and may spontaneously and
completely recover or with only mild sequelae within about
1 year with no dopaminergic medication [59, 61, 63, 64].
Bilateral pallidal necrosis or infarction is the char-
acteristic lesion of the parkinsonism induced by postis-
chemic/hypoxic encephalopathy. The typical lesion in globus
pallidus(GP)iswelldeﬁnedandusuallyextendsintointernal
capsule [56, 57, 59]. Some patients has the entire lentiform
nucleus (GP and putamen) injury and massive cerebral
white matter damage, comprised of cytotoxic edema and
diﬀuse demyelination/axonal destruction, as well as cortical
lesions [61, 64–67]. Magnetic resonance imaging (MRI)
[56, 57, 59, 64, 66–69] and autopsy [56, 59, 64, 66, 68, 69]
demonstrated that the postischemic/hypoxic parkinsonism
almostalwayshavebilateralbasalganglianecrosis/infarction,
but substantia nigra lesions are very rare [66]. In a literature
review, 2 of 86 patients with the parkinsonism acquired
from CA- or CO-intoxication had SN injury: in one patient,
MRI and autopsy revealed the bilateral SNR (SNC was
spared) and GPs necrosis [70]; in a second patient, MRI
disclosed bilateral pallidal and substantia nigral lesion [71].
In addition, MRI revealed that one such patient had only
the periventricular and deep white matter change no basal
ganglia injury [65].
Pallidal injury results in akinetic-rigid syndrome [59].
Delayed demyelination and axonal destruction also con-
tribute to developing the basal ganglia deterioration [59].
Although the white matter impairment is reversible, its
amelioration and disappearance is in accordance with the
complete recovery of the akinetic-rigid syndrome [64, 65].
Reduction of putaminal dopamine uptake due to the impair-
mentofpresynapticDAergicactivityinputamen(asopposed
to DAergic neuronal loss) is responsible for the development
of postischemic/hypoxic parkinsonism [64, 67].
The basal ganglia are especially vulnerable to hypoxia
[59]. The regional cerebral blood ﬂow (rCBF) is reduced
in the globus pallidus, the frontal and temporal cortex, and
the cerebral white matter during the delayed encephalopathy
[63]. Hypoxia-ischemia typically produces lesions in the
globus pallidus; and vascular insuﬃciency is a major mecha-
nism [56, 68].
The parkinsonism recovery is associated with the healing
or amelioration of injury in white matter and GPs [61, 63,
64, 67]. Consistent with this, levodopa anticholinergic drugs
are ineﬀective [56, 57, 61, 63].
Bhatia and Marsden studied 240 patients with motor
or behavioral disorders acquired from hypoxia and found
that bilateral lesions of the lentiform nuclei, either of
the globus pallidus or the putamen, caused parkinsonism
without SNC neurodegeneration [72]. Lesions in the globus
pallidus external (GPe) and internal (GPi) divisions lead to
the akinetic-rigid syndrome in men [73].
In conclusion, we detected deterioration of the GABAer-
gic system in substantia nigra pars reticulata (SNR) after
the moderate forebrain ischemia, which began at 4 weeks.
This was associated with a slowing of the traversal of
the beam-walking test at 8 weeks, despite the observation
that all the rats could perform the test without fault. The
coexistence of the neuronal loss of bilateral striatum, the
delayed degeneration of GABAergic system in SNR and the
disturbance of coordination, bradykinesia, provided in the
present study therefore may partly explain the Parkinsonism
development without DAergic neuronal loss in substantia
nigra par compata (SNC) in the postischemic/hypoxic
encephalopathy in patients. Thus, neuroprotective strategies
aimed at preserving GABAergic function within the substan-
tia nigra and improving rCBF in basal ganglia may alleviate
parkinsonism in the delayed encephalopathy.14 Cardiovascular Psychiatry and Neurology
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